期刊文献+

胃食管反流病的危险因素及相关心理因素分析并疗效观察 被引量:4

Analyzing the risk factors and related psychological factors in patients with gastroesophageal reflux disease and surveying the curative effect
下载PDF
导出
摘要 目的分析胃食管反流病(GERD)的危险因素及相关心理因素并观察疗效。方法随机选取2006年1月至2008年1月符合GERD诊断患者200例(GERD组)及健康对照者200例(对照组),调查两组的个人资料,分别采用RDQ量表及Zung抑郁自评量表(SDS)测评。比较两组的各种危险因素及GERD组患者治疗前后RDQ量表和SDS评分变化。结果GERD组高学历、城区居住、婚姻不稳定、有工作压力、高体重指数、有吸烟史、有饮酒史、有胃病家族史、使用非甾体抗炎药(NSAID)的比例均高于对照组(P均〈0.01)。GERD组治疗前RDQ量表评分〉12分有196例患者,治疗后有8例患者,治疗前后比较差异有统计学意义(P〈0.01)。GERD组治疗前SDS评分〉40分有18例患者,治疗后有3例患者,治疗前后比较差异有统计学意义(P〈0.01)。结论GERD患者存在较多危险因素,特别是心理因素,治疗消化系统疾病的同时需要进行综合心态调整治疗,避免过度肥胖、吸烟、饮酒、过量使用NSAID等。 Objective To analyze the risk factors and related psychological factors in patients with gastroesophageal reflux disease (GERD)and survey the curative effect. Methods All of 200 outpatients with GERD( GERD group ) and 200 healthy persons (control group)from January 2006 to January 2008 were randomly selected, and the personal data were investigated. The GERD questionnaire (RDQ) and the Zung-self-rating depression scale (SDS) test were used. Results In GERD group, the proportions of high education, city living, marriage instability ,heavy working pressure, high body mass index (BMI),smoking and drinking habit, peptic disease in family, using nonsteroidal anti-inflammatory drugs (NSAIDs) were higher than those in control group (P all 〈 0.01 ). After treatment, the patients in GERD group had lower scores in the RDQ and SDS test than those before treatment (P 〈 0.01 ). Conclusions There are many risk factors in patients with GERD, especially the psychological factors. The therapy of GERD should combine with psychotherapy and avoid high BMI, smoking, drinking and overusing the NSAID.
出处 《中国医师进修杂志(内科版)》 2008年第9期8-10,共3页 Chinese Journal of Postgraduates of Medicine
关键词 胃食管反流 危险因素 人体质量指数 心理学 Gastroesophageal reflux Risk factors Body mass index Psychology
  • 相关文献

参考文献7

二级参考文献25

  • 1Calabrese Carlo,Fabbri Anna,Areni Alessandra,Scialpi Carlo,Zahlane Desiree,Di Febo Giulio.Asthma and gastroesophageal reflux disease: Effect of long-term pantoprazole therapy[J].World Journal of Gastroenterology,2005,11(48):7657-7660. 被引量:10
  • 2李增裂.消化不良和临床流行病学[J].中国实用内科杂志,1995,15:5-6.
  • 3王伟岸 潘国宗 等.百忧解治疗难治性肠易激综合征的疗效观察[J].中国医学论坛报,2000,26:4-4.
  • 4徐勇勇 宇传华 陈平雁等.诊断和筛查试验的研究设计与分析[A].方积乾 主编.医学统计学与电脑实验:第2版[C].上海:上海科学技术出版社,2001.327-344.
  • 5[1]Armstrong D,Bennett JR,Blum AL,Dent J,Dombal MD,Galmiche JP,Lundell L,Margulies M,Richter E,Spechler SJ,Tytgat GNJ,Wallin L.The endoscopic assessment of esophagitis:a progress report on observer agreement.Gastroenterology,1996;111:85-92
  • 6[2]Soga T,Matsuura M,Kodama Y,Fujita T,Sekimoto I,Nishimura K,Yoshida S,Kutsumi H,Fujimoto S.Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis? J Gastroenterol,1999;34:435-440
  • 7[3]Escourrou J,Deprez P,Saaggioro A,Geldof H,Fischer R,Maier C.Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis.Aliment Pharmacol Ther,1999;13:1481-1491
  • 8[4]Festen HP,Schenk E,Tan G,Snel P,Nelis F.Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease:short-and long-term treatment.The Dutch Reflux Study Group.Am J Gastroenterol,1999;94:931-936
  • 9[6]Gallo S,Dibildox M,Moguel A,Di Silvio M,Rodriguez F,Almaguer I,Garcia C.Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade Ⅱ and Ⅲ.A prospective,double-blind,double-placebo study.Mexican clinical experience.Mexican Pantoprazole Study Group.Rev Gastroenterol Mex,1998;63:11-16
  • 10[8]Wurzer H,Schutze K,Bethke T,Fischer R,Luhmann R,Riesenhuber C.Efficacy and safety of pantoprazole in patients with gastroesophaageal reflux disease using an intravenous-oral regimen.Austrian Intravenous Pantoprazole Study Group.Hepatogastroenterology,1999;46:1809-1815

共引文献793

同被引文献52

引证文献4

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部